Company: PGEN
Filing Date: 2025-03-19
Form Type: 10-K
Source: 0001356090-25-000007
Chunk: 122

Company: PRECIGEN, INC.
Filing Date: 2025-03-19
Form: 10-K
Item: Item 7
Chunk 122
---
 $1,000 per share, together with warrants to purchase 52,666,669 shares of common stock for net proceeds of approximately  $78.5 million, after deducting offering expenses, which expenses had not been paid as of December 31, 2024. 

Cash Flows

The following table sets forth the significant sources and uses of cash for the periods set forth below (dollar amounts in thousands):

 Year Ended December 31, 202420232022 (In thousands)Net cash provided by (used in):Operating activities$(68,173)$(66,930)$(65,045)Investing activities(20,714)(3,087)226,417 Financing activities110,583 29,589 (155,292)Effect of exchange rate changes on cash, cash equivalents, and restricted cash(27)(320)(827)Net increase (decrease) in cash, cash equivalents, and restricted cash$21,669 $(40,748)$5,253 

Cash flows from operating activities:

In 2024, our net loss was $126.2 million, which includes the following significant noncash expenses and benefits totaling $55.1 million: (i) $40.3 million impairment losses, (ii) $9.5 million of stock-based compensation expense, (iii) $4.5 million of depreciation and amortization expense,  (iv) $2.9 million due to reclassification of cumulative translation losses, and (v) $0.6 million of shares issued as payment for services, partially offset by non-cash benefits of $1.8 million due to deferred income taxes and $0.9 million due to amortization of discounts on investments. In addition, changes in operating assets and liabilities provided $2.7 million of cash for operating activities. 

In 2023, our net loss was $95.9 million, which includes the following significant noncash expenses: (i) $9.9 million of stock-based compensation expense, (ii) $10.8 million impairment losses, (iii) $6.7 million of depreciation and amortization expense, offset by (iv) $1.8 million due to amortization of discounts on investments. In addition, changes in operating assets and liabilities increased cash from operating activities by $3.4 million.

In 2022, our net income was $28.3 million, which included a gain on sale of discontinued operations of $94.7 million